The Moderate Alcohol and Cardiovascular Health Trial: Public health advocates should support good science,not undermine it

Spiegelman D Lovato LC Khudyakov P , et al. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk. Eur J Prev Cardiol, In press.

Rabin RC. Federal agency courted alcohol industry to fund study on benefits of moderate drinking, https://www.nytimes.com/2018/03/17/health/nih-alcohol-study-liquor-industry.html?auth=login-email&login=email (2018, accessed 16 January 2020).

Foundation for the National Institutes of Health. 2018 Annual report, https://fnih.org/2018-annual-report/assets/pdf/FNIH-2018-AR.pdf (2019, accessed 16 January 2020).

Kloner RA Rezkalla SH. To drink or not to drink? That is the question. Circulation 2007; 116: 1306–1317.

Siegel MB. Anheuser Busch “Smart Drinking” initiative is a complete farce, http://tobaccoanalysis.blogspot.com/2016/05/anheuser-busch-smart-drinking.html (2016, accessed 16 January 2020).

Padon AA Rimal RN Siegel M , et al. Alcohol brand use of youth-appealing advertising and consumption by youth and adults. J Public Health Res 2018; 7: 1269.

Padon A Rimal RN DeJong W , et al. Assessing youth-appealing content in alcohol advertisements: Application of a Content Appealing to Youth (CAY) Index. Health Commun 2017; 33: 164–173.

Siegel M DeJong W Cioffi D , et al. Do alcohol advertisements for brands popular among underage drinkers have greater appeal among youth and young adults? Subst Abuse 2016; 37: 222–229.

Chaloupka FJ Powell LM Warner KE. The use of excise taxes to reduce tobacco, alcohol, and sugary beverage consumption. Annu Rev Public Health 2019; 40: 187–201.

DeJong W. Treating the alcohol industry as a pariah is a losing proposition. Prev File: Alcohol Tob Other Drugs 2006; 11–13.

Anhueser-Busch InBev. Reducing the harmful use of alcohol and improving road safety: AB InBev’s progress report on its global smart drinking goals and contribution to United Nations Sustainable Development Goals 3 and 17. New York: AB InBev, 2018.

Rehm J Lachenmeier DW Llopis EJ , et al. Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol. Lancet Gastroenterol Hepatol 2016; 1: 78–83.

Di Castelnuovo A Costanzo S di Giuseppe R , et al. Alcohol consumption and cardiovascular risk: Mechanisms of action and epidemiologic perspectives. Future Cardiol 2009; 5: 467–477.

Ronksley PE Brien SE Turner BJ , et al. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ 2011; 342: d671.

Wood AM Kaptoge S Butterworth AS , et al. Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018; 391: 1513–1523.

Brien SE Ronksley PE Turner BJ , et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: Systematic review and meta-analysis of interventional studies. BMJ 2011; 342: d636.

Fillmore KM Kerr WC Stockwell T , et al. Moderate alcohol use and reduced mortality risk: Systematic error in prospective studies. Addict Res Theory 2006; 14: 101–132.

Romieu I Scoccianti C Chajes V , et al. Alcohol intake and breast cancer in the European Prospective investigation into Cancer and Nutrition (EPIC) study. Proc Am Assoc Cancer Res 2014; 1271.